Andrew Hirsch named Chief Executive Officer of C4 Therapeutics
WATERTOWN: C4 Therapeutics (C4T), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins through degradation, announced the hiring of Andrew Hirsch as the Company’s incoming chief executive officer. Mr. Hirsch comes to C4T from…